AI-generated summary
The authors review in-office procedural treatments for dry eye disease, which they describe as increasingly common and multifactorial. They report that most newer devices target meibomian gland dysfunction, including thermal devices, intense pulsed light, radiofrequency and gland probing, while options for aqueous deficiency remain limited and still rely mainly on topical treatments. This is a narrative review and the abstract does not report pooled outcome data.
- Who or what was studied
- patients with dry eye disease
- Limits stated in the abstract
- The abstract describes a narrative review and does not report the number of included studies or quantitative efficacy results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.